PHASE I ACCELERATED DOSE-ESCALATING SAFETY AND PHARMACOKINETIC (PK) STUDY OF GGTI-2418, A NOVEL GERANYLGERANYLTRANSFERASE I INHIBITOR IN PATIENTS WITH REFRACTORY SOLID TUMORSP. J. O'Dwyer,M. Gallagher, B. Nguyen,M. J. Waddell,E. G. ChioreanANNALS OF ONCOLOGY（2010）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
